Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESS: Induced Hypertension in Acute LVO Ischemic Stroke
NCT04218773Phase 1Terminated
- Sponsor
- Yale University
- Start
- Sep 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of phenylephrine and norepinephrine in ischemic stroke (2 arms), sponsored by Yale University. Primary endpoints: Ability to achieve and maintain systolic blood pressure goals at 2.5 hours and Number of patients with symptomatic intracranial hemorrhage at 72 hours. Started Sep 2020; status: terminated.
02
Drugs
phenylephrinenorepinephrine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04218773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04218773.